Skip to main content
. 2014 Jan 16;110(4):984–990. doi: 10.1038/bjc.2013.815

Table 2. Univariate survival analyses (n=176).

Characteristics OS (CI) P-valuea HR (CI)
Age, years
⩽64 13.7 (10.0–17.4) 0.52 0.90 (0.64–1.25)
>64
13.9 (10.3–17.6)
 
 
Sex
Female 12.0 (8.2–15.9) 0.54 0.88 (0.58–1.33)
Male
13.9 (10.7–17.2)
 
 
Histology
Epithelioid 14.6 (10.5–18.7) <0.01 2.01 (1.31–3.10)
Non-epithelioid
6.5 (2.9–10.1)
 
 
Stageb
Early stage 18.6 (0–39.8) 0.01 2.09 (1.17–3.76)
Late stage
12.8 (9.7–15.9)
 
 
Treatment
Best supportive care 6.5 (3.8–9.3) <0.01 2.81 (1.75–4.51)
Chemo- and/or radiotherapy 12.6 (8.7–16.5)   2.03 (1.33–3.10)
Multimodality treatment including radical surgery
30.9 (12.9–48.9)
 
1
Fibrinogen
High fibrinogen 8.5 (6.2–10.7) <0.01 2.11 (1.49–2.99)
Low fibrinogen 19.1 (14.5–23.7)    

Abbreviations: CI=confidence interval; HR=hazard ratio; OS=overall survival.

a

Two-sided log-rank test.

b

Missing cases: n=26 (14.8%).